Published in N Engl J Med on February 06, 1997
New thrombopoietic growth factors. Blood (2007) 1.39
Clinical indications for thrombopoietin and thrombopoietin-receptor agonists. Transfus Med Hemother (2013) 0.92
Thrombopoietin and hematopoietic stem cells. Cell Cycle (2011) 0.91
Thrombopoietin receptor agonists in primary immune thrombocytopenia. Semin Hematol (2013) 0.81
Considerations in the management of hepatitis C virus-related thrombocytopenia with eltrombopag. Saudi J Gastroenterol (2010) 0.81
Toxicities of the thrombopoietic growth factors. Semin Hematol (2010) 0.80
Thrombopoietin--clinically realized? N Engl J Med (1997) 0.78
Thrombopoietin and platelet production in chronic immune thrombocytopenia. Hematol Oncol Clin North Am (2009) 0.77
Safety and feasibility of romiplostim treatment for patients with persistent thrombocytopenia after allogeneic stem cell transplantation. Bone Marrow Transplant (2015) 0.75
Role of romiplostim in splenectomized and nonsplenectomized patients with immune thrombocytopenia. Immunotargets Ther (2016) 0.75
New advances in the treatment of adult chronic immune thrombocytopenic purpura: role of thrombopoietin receptor-stimulating agents. Biologics (2009) 0.75
Eltrombopag--a novel approach for the treatment of chronic immune thrombocytopenic purpura: review and safety considerations. Drug Des Devel Ther (2010) 0.75
A platelet-dependent serum factor that stimulates the proliferation of arterial smooth muscle cells in vitro. Proc Natl Acad Sci U S A (1974) 9.94
Reduction by granulocyte colony-stimulating factor of fever and neutropenia induced by chemotherapy in patients with small-cell lung cancer. N Engl J Med (1991) 6.33
Studies of hypercholesterolemia in the nonhuman primate. I. Changes that lead to fatty streak formation. Arteriosclerosis (1984) 4.40
EORTC guidelines for the use of granulocyte-colony stimulating factor to reduce the incidence of chemotherapy-induced febrile neutropenia in adult patients with lymphomas and solid tumours. Eur J Cancer (2006) 3.78
2000 update of recommendations for the use of hematopoietic colony-stimulating factors: evidence-based, clinical practice guidelines. American Society of Clinical Oncology Growth Factors Expert Panel. J Clin Oncol (2000) 3.38
Electroacupuncture for control of myeloablative chemotherapy-induced emesis: A randomized controlled trial. JAMA (2000) 3.13
An association between renal cell carcinoma and lymphoid malignancies. A case series of eight patients. Cancer (1996) 3.12
In a minority of gay men, sexual risk practice indicates strategic positioning for perceived risk reduction rather than unbridled sex. AIDS Care (2002) 3.01
Pegfilgrastim: the promise of pegylation fulfilled. Ann Oncol (2003) 3.00
Hyperlipidemia and atherosclerosis. Science (1976) 2.55
Letter: Eye injuries in hockey. Can Med Assoc J (1974) 2.52
Blinded, randomized, multicenter study to evaluate single administration pegfilgrastim once per cycle versus daily filgrastim as an adjunct to chemotherapy in patients with high-risk stage II or stage III/IV breast cancer. J Clin Oncol (2002) 2.46
Sustaining safe sex: a longitudinal study of a sample of homosexual men. AIDS (1993) 2.35
Effect of granulocyte colony stimulating factor on neutropenia induced by cytotoxic chemotherapy. Lancet (1988) 2.28
Thrombocytopenia caused by the development of antibodies to thrombopoietin. Blood (2001) 2.21
Renal cell carcinoma: prognostic significance of incidentally detected tumors. J Urol (2000) 2.13
Response to injury and atherogenesis. Am J Pathol (1977) 2.09
Recombinant granulocyte colony stimulating factor reduces the infectious complications of cytotoxic chemotherapy. Eur J Cancer (1993) 2.08
Rising incidence of bronchioloalveolar lung carcinoma and its unique clinicopathologic features. Cancer (1994) 1.95
The usefulness of F-18 deoxyglucose whole-body positron emission tomography (PET) for re-staging of renal cell cancer. Clin Nephrol (2002) 1.85
Interferon-alpha therapy during pregnancy in chronic myelogenous leukaemia and hairy cell leukaemia. Br J Haematol (1992) 1.75
Racial differences in the prevalence of monoclonal gammopathy in a community-based sample of the elderly. Am J Med (1998) 1.75
Hemiarthroplasty versus internal fixation for displaced intracapsular hip fractures in the elderly. A randomised trial of 455 patients. J Bone Joint Surg Br (2002) 1.73
A pilot trial assessing the efficacy of paroxetine hydrochloride (Paxil) in controlling hot flashes in breast cancer survivors. Ann Oncol (2000) 1.72
Posthumous diagnosis of long QT syndrome from neonatal screening cards. Heart Rhythm (2010) 1.65
Evaluating organizational design to assure technology transfer: the case of the Community Clinical Oncology Program. J Natl Cancer Inst (1989) 1.65
Gadolinium-enhanced MR cisternography to evaluate dural leaks in intracranial hypotension syndrome. AJNR Am J Neuroradiol (2007) 1.63
Ulcerative colitis and sensorineural hearing loss: is there a relationship? J Clin Gastroenterol (1982) 1.59
A scale of optimism-scepticism in the context of HIV treatments. AIDS Care (2000) 1.58
Brief report: intragenic deletion of the KALIG-1 gene in Kallmann's syndrome. N Engl J Med (1992) 1.58
Beta-cell function and visceral fat in lactating women with a history of gestational diabetes. Metabolism (2001) 1.54
Quantified superiority of cognitive behaviour therapy to antidepressant drugs: a challenge to an earlier meta-analysis. Acta Psychiatr Scand (2008) 1.51
Combination chemotherapy with or without thoracic radiotherapy in limited-stage small-cell lung cancer: a randomized trial of the Southeastern Cancer Study Group. J Clin Oncol (1993) 1.51
HIV risk and communication between regular partners in a cohort of HIV-negative gay men. AIDS Care (2006) 1.49
Prophylactic platelet transfusions from healthy apheresis platelet donors undergoing treatment with thrombopoietin. Blood (2001) 1.46
Erythropoiesis-stimulating agents in oncology: a study-level meta-analysis of survival and other safety outcomes. Br J Cancer (2010) 1.46
Digital vasculitis associated with interferon therapy. Am J Med (1992) 1.45
Trends in heterosexual tertiary students' knowledge of HIV and intentions to avoid people who might have HIV. AIDS Care (1996) 1.45
Cost-effectiveness of interferon-alpha and conventional chemotherapy in chronic myelogenous leukemia. Ann Intern Med (1996) 1.43
The functional dissection of human peripheral null cells with respect to antibody-dependent cellular cytotoxicity and natural killing. Eur J Immunol (1979) 1.41
Can platelet-rich plasma be used safely in intra-abdominal operations? Bratisl Lek Listy (2016) 1.39
Sarcomatoid renal cell carcinoma: biologic behavior, prognosis, and response to combined surgical resection and immunotherapy. J Clin Oncol (1999) 1.36
Chronic illness and functional limitation in Ontario children: findings of the Ontario Child Health Study. CMAJ (1986) 1.36
Mozambique child soldier life outcome study: lessons learned in rehabilitation and reintegration efforts. Glob Public Health (2006) 1.34
Analysis of Australian Crohn's disease pedigrees refines the localization for susceptibility to inflammatory bowel disease on chromosome 16. Ann Hum Genet (1998) 1.34
Treatment of chemotherapy-induced neutropenia by subcutaneously administered granulocyte colony-stimulating factor with optimization of dose and duration of therapy. J Clin Oncol (1989) 1.32
Randomized trial of vinorelbine compared with fluorouracil plus leucovorin in patients with stage IV non-small-cell lung cancer. J Clin Oncol (1996) 1.31
HIV treatments optimism and sexual behaviour among gay men in Sydney and Melbourne. AIDS (1999) 1.29
Cultures of sexual adventurism as markers of HIV seroconversion: a case control study in a cohort of Sydney gay men. AIDS Care (1998) 1.28
Effects of megakaryocyte growth and development factor on platelet production, platelet life span, and platelet function in healthy human volunteers. Blood (2000) 1.26
A comparison of gene transfer methods in human dendritic cells. Cancer Gene Ther (1997) 1.25
The mouse specific-locus test with agents other than radiations: interpretation of data and recommendations for future work. Mutat Res (1981) 1.24
Loss of heterozygosity mapping at chromosome arm 16q in 712 breast tumors reveals factors that influence delineation of candidate regions. Cancer Res (2001) 1.23
Alternative extracellular and cytoplasmic domains of the integrin alpha 7 subunit are differentially expressed during development. J Biol Chem (1993) 1.23
Randomized, dose-escalation study of SD/01 compared with daily filgrastim in patients receiving chemotherapy. J Clin Oncol (2000) 1.21
Vasculopathic changes in the cerebral arterial system with neurobrucellosis. AJNR Am J Neuroradiol (2006) 1.21
Thrombopoietin therapy increases platelet yields in healthy platelet donors. Blood (2001) 1.20
The role of positron emission tomography in oncology and other whole-body applications. Semin Nucl Med (1992) 1.19
Mechanisms of signal transduction mediated by oxidized lipids: the role of the electrophile-responsive proteome. Biochem Soc Trans (2004) 1.16
In vitro effects of 4-hydroperoxycyclophosphamide on human immunoregulatory T subset function. I. Selective effects on lymphocyte function in T-B cell collaboration. J Exp Med (1982) 1.16
Dirty, diseased and undeserving: the positioning of HIV positive women. Soc Sci Med (1996) 1.15
Is adrenalectomy a necessary component of radical nephrectomy? UCLA experience with 511 radical nephrectomies. J Urol (2000) 1.15
Near-miss SIDS due to Brugada syndrome. Arch Dis Child (2005) 1.14
Cisplatin plus etoposide consolidation following cyclophosphamide, doxorubicin, and vincristine in limited small-cell lung cancer. J Clin Oncol (1988) 1.14
Primary hepatocellular carcinoma in idiopathic hemochromatosis after reversal of cirrhosis. Gastroenterology (1988) 1.13
L-tetramisole. Enhancement of human lymphocyte response to antigen. Clin Exp Immunol (1975) 1.11
Novel erythropoiesis stimulating protein (NESP) for the treatment of anaemia of chronic disease associated with cancer. Br J Cancer (2001) 1.10
Immunoregulatory T cell function in multiple myeloma. J Clin Invest (1981) 1.10
Cloning, characterization, and chromosomal location of a novel human K+-Cl- cotransporter. J Biol Chem (1999) 1.09
Positron emission tomography diagnosis of pulmonary metastases in osteogenic sarcoma. Am J Clin Oncol (1994) 1.08
Differences between HIV-positive gay men who 'frequently', 'sometimes' or 'never' engage in unprotected anal intercourse with serononconcordant casual partners: positive Health cohort, Australia. AIDS Care (2007) 1.08
Measurement of quality of life in patients with lung cancer in multicenter trials of new therapies. Psychometric assessment of the Lung Cancer Symptom Scale. Cancer (1994) 1.08
Liposarcoma in the epidural space. Spine (Phila Pa 1976) (2000) 1.07
The impact of the granulocyte colony-stimulating factor on chemotherapy dose intensity and cancer survival: a systematic review and meta-analysis of randomized controlled trials. Ann Oncol (2013) 1.06
Control of cancer-related anemia with erythropoietic agents: a review of evidence for improved quality of life and clinical outcomes. Ann Oncol (2003) 1.06
Mutation analysis of the Fanconi anaemia A gene in breast tumours with loss of heterozygosity at 16q24.3. Br J Cancer (1999) 1.06
Increasing proportions of Australian gay and homosexually active men engage in unprotected anal intercourse with regular and with casual partners. AIDS Care (2002) 1.06
Improved survival in advanced Hodgkin's disease with the use of combined modality therapy. Int J Radiat Oncol Biol Phys (1990) 1.06
Erythrocyte anisocytosis. Visual inspection of blood films vs automated analysis of red blood cell distribution width. Arch Intern Med (1988) 1.06
The response of rabbit lymphocytes to mitogens and alloantigens: evidence for T cell heterogeneity. J Immunol (1974) 1.05
Identification of the T cell subset that produces human gamma interferon. J Immunol (1982) 1.04
Pharmacology of the colony-stimulating factors. Trends Pharmacol Sci (1989) 1.04
Interventions for treating acute Achilles tendon ruptures. Cochrane Database Syst Rev (2004) 1.04
Renal cell carcinoma: recent progress and future directions. Cancer Res (1997) 1.02
Pachymeningitis associated with a pulmonary nodule. Neurosurgery (1991) 1.02
GPR56, a novel secretin-like human G-protein-coupled receptor gene. Genomics (1999) 1.01
Using plasma transforming growth factor beta-1 during radiotherapy to select patients for dose escalation. J Clin Oncol (2001) 1.00
Intrathecal gadolinium-enhanced MR cisternography in the evaluation of CSF leakage. AJNR Am J Neuroradiol (2009) 1.00
Using a community clinical trials network for treatment, prevention, and control research: assuring access to state-of-the-art cancer care. Cancer Invest (1995) 1.00
Whole-body FDG-PET imaging for staging of Hodgkin's disease and lymphoma. J Nucl Med (1997) 0.99
Clinical utility of erythrocyte sedimentation rate and plasma protein analysis in the elderly. Am J Med (1987) 0.98
Clinical experience with recombinant human granulocyte colony-stimulating factor and granulocyte macrophage colony-stimulating factor. Semin Hematol (1989) 0.98